Literature DB >> 29631809

Intracellular complement activation-An alarm raising mechanism?

M P Reichhardt1, S Meri2.   

Abstract

It has become increasingly apparent that the complement system, being an ancient defense mechanism, is not operative only in the extracellular milieu but also intracellularly. In addition to the known synthetic machinery in the liver and by macrophages, many other cell types, including lymphocytes, adipocytes and epithelial cells produce selected complement components. Activation of e.g. C3 and C5 inside cells may have multiple effects ranging from direct antimicrobial defense to cell differentiation and possible influence on metabolism. Intracellular activation of C3 and C5 in T cells is involved in the maintenance of immunological tolerance and promotes differentiation of T helper cells into Th1-type cells that activate cell-mediated immune responses. Adipocytes are unique in producing many complement sensor proteins (like C1q) and Factor D (adipsin), the key enzyme in promoting alternative pathway amplification. The effects of complement activation products are mediated by intracellular and cell membrane receptors, like C3aR, C5aR1, C5aR2 and the complement regulator MCP/CD46, often jointly with other receptors like the T cell receptor, Toll-like receptors and those of the inflammasomes. These recent observations link complement activation to cellular metabolic processes, intracellular defense reactions and to diverse adaptive immune responses. The complement components may thus be viewed as intracellular alarm molecules involved in the cellular danger response.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Adaptive immunology; C3; C3a; C5; C5a; C5aR1; C5aR2; Cellular homeostasis; Complement; Complement signaling; Inflammasome; Intracellular complement; Intracellular defense; Metabolism

Mesh:

Substances:

Year:  2018        PMID: 29631809     DOI: 10.1016/j.smim.2018.03.003

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  18 in total

Review 1.  Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies.

Authors:  Alicia J Jenkins; Maria B Grant; Julia V Busik
Journal:  Diabetologia       Date:  2022-02-11       Impact factor: 10.460

Review 2.  Gaucher disease: Basic and translational science needs for more complete therapy and management.

Authors:  Gregory A Grabowski; Armand H M Antommaria; Edwin H Kolodny; Pramod K Mistry
Journal:  Mol Genet Metab       Date:  2020-12-29       Impact factor: 4.797

3.  Autotransporter-Mediated Display of Complement Receptor Ligands by Gram-Negative Bacteria Increases Antibody Responses and Limits Disease Severity.

Authors:  Kristen M Holland-Tummillo; Lauren E Shoudy; Donald Steiner; Sudeep Kumar; Sarah J Rosa; Prachi Namjoshi; Anju Singh; Timothy J Sellati; Edmund J Gosselin; Karsten Ro Hazlett
Journal:  Pathogens       Date:  2020-05-14

Review 4.  NFκB and Kidney Injury.

Authors:  Ning Song; Friedrich Thaiss; Linlin Guo
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

5.  Complement Receptor C5aR1 Inhibition Reduces Pyroptosis in hDPP4-Transgenic Mice Infected with MERS-CoV.

Authors:  Yuting Jiang; Junfeng Li; Yue Teng; Hong Sun; Guang Tian; Lei He; Pei Li; Yuehong Chen; Yan Guo; Jiangfan Li; Guangyu Zhao; Yusen Zhou; Shihui Sun
Journal:  Viruses       Date:  2019-01-09       Impact factor: 5.048

6.  PepO is a target of the two-component systems VicRK and CovR required for systemic virulence of Streptococcus mutans.

Authors:  Lívia A Alves; Tridib Ganguly; Érika N Harth-Chú; Jessica Kajfasz; José A Lemos; Jacqueline Abranches; Renata O Mattos-Graner
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

7.  Serum amyloid P component is an essential element of resistance against Aspergillus fumigatus.

Authors:  Andrea Doni; Raffaella Parente; Ilaria Laface; Elena Magrini; Cristina Cunha; Federico Simone Colombo; João F Lacerda; António Campos; Sarah N Mapelli; Francesca Petroni; Rémi Porte; Tilo Schorn; Antonio Inforzato; Toine Mercier; Katrien Lagrou; Johan Maertens; John D Lambris; Barbara Bottazzi; Cecilia Garlanda; Marina Botto; Agostinho Carvalho; Alberto Mantovani
Journal:  Nat Commun       Date:  2021-06-18       Impact factor: 14.919

Review 8.  Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis.

Authors:  Cheng-Jie Lin; Zhi-Gao Hu; Guan-Dou Yuan; Biao Lei; Song-Qing He
Journal:  World J Hepatol       Date:  2018-10-27

9.  Complement in Human Pre-implantation Embryos: Attack and Defense.

Authors:  Martin P Reichhardt; Karolina Lundin; A Inkeri Lokki; Gaëlle Recher; Sanna Vuoristo; Shintaro Katayama; Juha S Tapanainen; Juha Kere; Seppo Meri; Timo Tuuri
Journal:  Front Immunol       Date:  2019-09-18       Impact factor: 7.561

10.  Selective and marked decrease of complement receptor C5aR2 in human thoracic aortic aneurysms: a dysregulation with potential inflammatory effects.

Authors:  Mieke C Louwe; Trine Ranheim; Margrethe Holt; Bjørn E Seim; Jonas Øgaard; Maria B Olsen; Per R Woldbæk; J P Kvitting; Pål Aukrust; Arne Yndestad; Tom Eirik Mollnes; Per H Nilsson
Journal:  Open Heart       Date:  2019-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.